Permissive Azotemia During Acute Kidney Injury Enables More Rapid Renal Recovery and Less Renal Fibrosis: a Hypothesis and Clinical Development Plan
Overview
Authors
Affiliations
Preclinical models of acute kidney injury (AKI) consistently demonstrate that a uremic milieu enhances renal recovery and decreases kidney fibrosis. Similarly, significant decreases in monocyte/macrophage infiltration, complement levels, and other markers of inflammation in the injured kidney are observed across multiple studies and species. In essence, decreased renal clearance has the surprising and counterintuitive effect of being an effective treatment for AKI. In this Perspective, the author suggests a hypothesis describing why the uremic milieu is kidney protective and proposes a clinical trial of 'permissive azotemia' to improve renal recovery and long-term renal outcomes in critically ill patients with severe AKI.
Focus on oliguria during renal replacement therapy.
Zhang Q, Wang X, Chao Y, Liu L J Anesth. 2024; 38(5):681-691.
PMID: 38777933 PMC: 11415420. DOI: 10.1007/s00540-024-03342-4.
Dynamic cellular changes in acute kidney injury caused by different ischemia time.
Shan D, Wang Y, Chang Y, Cui H, Tao M, Sheng Y iScience. 2023; 26(5):106646.
PMID: 37168554 PMC: 10165188. DOI: 10.1016/j.isci.2023.106646.